NASDAQ: MENS
Jyong Biotech Revenue

Jyong Biotech revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MENS annual revenue was $0.0, with N/A growth year-over-year.

MENS revenue history

Current Revenue
$0.0
Current Earnings
-$4.7M
Current Profit Margin
0%

Be the first to know when MENS announces revenue.

MENS Revenue History By Year

MENS Yearly RevenueMENS RevenueMENS ChangeMENS Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A

1 of 1

Jyong Biotech Revenue FAQ

What was MENS's revenue last quarter?

Jyong Biotech (NASDAQ: MENS) reported Q4 2025 revenue of N/A up N/A year over year. In the same quarter last year, Jyong Biotech's revenue was N/A.

What was Jyong Biotech's revenue in 2025?

Jyong Biotech's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does Jyong Biotech make in a day?

Based on Jyong Biotech annual revenue for the past four years, MENS makes an average of $0.00 per day.

What was Jyong Biotech's annual revenue growth in the past year?

As of Q2 2026, Jyong Biotech's revenue has grown null year over year. Jyong Biotech's revenue in the past year totaled $0.00.

How much does Jyong Biotech make in a year?

Jyong Biotech's revenue by year for the past four years is:
  • Jyong Biotech's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
  • Jyong Biotech's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
  • Jyong Biotech's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Jyong Biotech's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.